Absorption, metabolism and health effects of dietary flavonoids in man

Biomedicine and Pharmacotherapy

Volumn 51, Issue 8, 1997, Pages 305-310

  Hollman, P C H ^b   Katan, M B ^a  

^a WAGENINGEN UNIVERSITY   (Netherlands)

^b NONE

Author keywords

Absorption; Epidemiology; Flavonoids

Indexed keywords

FLAVONOID;

CANCER PREVENTION; DRUG ABSORPTION; DRUG METABOLISM; HUMAN; ISCHEMIC HEART DISEASE; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0030775534     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0753-3322(97)88045-6     Document Type: Article

References (37)

1. Aeschbacher HU, Meier H, Ruch E. Nonmutagenicity in vivo of the food flavonol quercetin. Nutr Cancer 1982;4:90-8
2. Bergmark C, Wu R, de Faire U, Lefvert AK, Swedenborg J. Patients with early-onset peripheral vascular disease have increased levels of autoantibodies against oxidized LDL. Arterioscler Thromb Vasc Biol 1995;15:441-5
3. Block G, Patterson B, Subar A. Fruit, vegetables, and cancer prevention: a review of epidemiological evidence. Nutr Cancer 1992;18:1-29
4. Bors W, Heller W, Michel C, Saran M. Flavonoids as antioxidants: determination of radical-scavenging efficiencies. Method Enzymol 1990;186:343-55
5. de Whalley C, Rankin SM, Hoult JRS, Jessup W, Leake DS. Flavonoids inhibit the oxidative modification of low density lipoproteins by macrophages. Biochem Pharmacol 1990;39:1743-50
6. Fraga CG, Martino VS, Ferraro GE, Coussio JF, Boveris A. Flavonoids as antioxidants evaluated by in vitro and in situ liver chemiluminescence. Biochem Pharmacol 1987;36:717-20
7. Goldbohm RA, van den Brandt PA, Hertog MGL et al. Flavonoid intake and risk of cancer: a prospective cohort study. Am J Epidemiol 1995;141(suppl):s61(abstr)
8. Griffiths LA. Mammalian metabolism of flavonoids. In: Harborne J, Mabry T, eds. The Flavonoids: Advances in Research. London: Chapman and Hall, 1982;681-718
9. Gugler R, Leschik M, Dengler HJ. Disposition of quercetin in man after single oral and intravenous doses. Eur J Clin Pharmacol 1975;9:229-34
10. Hackett AM. The metabolism of flavonoid compounds in mammals. In: Cody V, Middleton E, Harborne J, eds. Plant Flavonoids in Biology and Medicine. Biochemical, Pharmacological, Structure-Activity Relationships. New York: Alan R Liss Inc, 1986;177-94
11. Halliwell B. Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? Lancet 1994;344:721-4
12. Hertog MGL, Hollman PCH, Katan MB. Content of potentially anticarcinogenic flavonoids of 28 vegetables and 9 fruits commonly consumed in the Netherlands. J Agric Food Chem 1992;40:2379-83
13. Hertog MGL, Feskens EJM, Hollman PCH, Katan MB, Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet 1993;342:1007-11
14. Hertog MGL, Hollman PCH, van de Putte B. Content of potentially anticarcinogenic flavonoids of tea infusions, wines, and fruit juices. J Agric Food Chem 1993;41:1242-6
15. Hertog MGL, Feskens EJM, Hollman PCH, Katan MB, Kromhout D. Dietary flavonoids and cancer risk in the Zutphen Elderly Study. Nutr Cancer 1994;22:175-84
16. Hertog MGL, Kromhout D, Aravanis C et al. Flavonoid intake and long-term risk of coronary heart disease and cancer in the Seven Countries Study. Arch Intern Med 1995;155:381-6
17. Hollman PCH, de Vries JHM, van Leeuwen SD, Mengelers MJB, Katan MB. Absorption of dietary quercetin glycosides and quercetin in healthy ileostomy volunteers. Am J Clin Nutr 1995;62:1276-82
18. Hollman PCH, van Trijp JMP, Buysman MNCP, van der Gaag MS, Mengelers MJB, de Vries JHM, Katan MB. Relative bioavailability of the antioxidant quercetin from various foods in man. 1997 (submitted for publication)
19. Huang MT, Ferraro T. Phenolic compounds in food and cancer prevention. In: Huang MT, Ho C, Lee CY, eds. Phenolic Compounds in Food and their Effects on Health. II. Antioxidants & Cancer Prevention. Washington DC: American Chemical Society, 1992;8-34
20. Jha P, Flather M, Lonn E, Farkouh M, Yusuf S. The antioxidant vitamins and cardiovascular disease. A critical review of epidemiologic and clinical trial data. Ann Intern Med 1995;123:860-72
21. Kandaswami C, Middleton E Jr. Free radical scavenging and antioxidant activity of plant flavonoids. Adv Exp Med Biol 1994;366:351-76
22. Keli SO, Hertog MGL, Feskens EJM, Kromhout D. Flavonoids, antioxidant vitamins and risk of stroke. The Zutphen study. Arch Intern Med 1996;156:637-42
23. Knekt P, Järvinen R, Reunanen A, Maatela J. Flavonoid intake and coronary mortality in Finland: a cohort study. Br Med J 1996;312:478-81
24. Kühnau J. The Flavonoids. A class of semi-essential food components: their role in human nutrition. World Rev Nutr Diet 1976;24:117-91
25. MacGregor JT, Wehr CM, Manners GD, Jurd L, Minkler JL, Carrano AV. In vivo exposure to plant flavonols. Influence on frequencies of micronuclei in mouse erythrocytes and sister-chromatid exchange in rabbit lymphocytes. Mutat Res 1983;124:255-70
26. Middleton E, Kandaswami C. The impact of plant flavonoids on mammalian biology: implications for immunity, inflammation and cancer. In: Harborne JB, ed. The Flavonoids: Advances in Research since 1986. London: Chapman and Hall, 1994;619-52
27. Ratty AK. Effects of flavonoids on nonenzymatic lipid peroxidation: structure-activity relationship. Biochem Med Metab Biol 1988;39:69-79
28. Rice-Evans CA, Miller NJ, Paganga G. Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radical Biol Med 1996;20:933-56
29. Rimm EB, Katan MB, Ascherio A, Stampfer MJ, Willett WC. Relation between intake of flavonoids and risk for coronary heart disease in male health professionals. Ann Intern Med 1996;125:384-9
30. Rusznyàk S, Szent-Györgyi A. Vitamin P: flavonols as vitamins. Nature 1936;138:27
31. Salonen JT, Ylä-Herttuala S, Yamamoto R, Butler S, Korpela H, Salonen R, Nyyssönen K, Palinski W, Witztum JL. Autoantibody against oxidised LDL and progression of carotid atherosclerosis. Lancet 1992;339:883-7
32. Shaikh M, Martini S, Quiney JR, Baskerville P, La Ville AE, Browse NL, Duffield R, Turner PR, Lewis B. Modified plasma-derived lipoproteins in human atherosclerotic plaques. Atherosclerosis 1988;69:165-72
33. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: modifications of low density lipoprotein that increase its atherogenicity. N Engl J Med 1989;320:915-24
34. Steinmetz KA, Potter JD. Vegetables, fruit and cancer. I. Epidemiology. Cancer Cause Control 1991;2:325-57
35. Sugimura T, Nagao M, Matsushima T et al. Mutagenicity of flavone derivatives. Proc Jpn Acad 1977;53:194-7
36. Ueno I, Nakano N, Hirono I. Metabolic fate of [14C]quercetin in the ACI rat. Jpn J Exp Med 1983;53:41-50
37. Wattenberg LW. Inhibition of carcinogenesis by minor dietary constituents. Cancer Res 1992;52(suppl):2085S-91S